Scopolamine
Back to searchMolecule Structure
Scientific Name
Scopolamine
Description of the Drug
Scopolamine is a belladonna alkaloid with anticholinergic effects indicated for the treatment of nausea and vomiting associated with motion sickness and postoperative nausea and vomiting (PONV).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00747
http://www.drugbank.ca/drugs/DB00747
Brand Name(s)
Isoptpo Hyoscine, Scopolamine, Transderm scop
Company Owner(s)
Padagis Us Llc, Riconpharma Llc, Actavis Laboratories Ut Inc, Mylan Technologies Inc, Baxter Healthcare Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL16226 | |||
Human Metabolome Database | HMDB0003573 | |||
DrugBank | DB00747 | |||
PubChem: Thomson Pharma | 152161014 | 16821414 | ||
NMRShiftDB | 60026753 | |||
LINCS | LSM-46039 | |||
BindingDB | 50240039 | |||
EPA CompTox Dashboard | DTXSID6023573 | |||
Metabolights | MTBLC16794 | |||
Brenda | 5612 | |||
Rhea | 16794 | |||
Guide to Pharmacology | 330 | |||
rxnorm | SCOPOLAMINE HYDROBROMIDE | SCOPOLAMINE | ISOPTO HYOSCINE | TRANSDERM SCOP |
ChEBI | 16794 | |||
ZINC | ZINC000100037020 |